SAYWARD MCCULLOUGH: Open Payments
NPI 1275158792 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,785 in 116 payments from 17 companies in 2025. Trend: 2023 $1,688 · 2024 $1,078 · 2025 $2,785
Food & beverage: $2,781Education: $4
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $545 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $336 |
| Otsuka America Pharmaceutical, Inc. | 10 | $306 |
| Janssen Pharmaceuticals, Inc | 9 | $303 |
| E.R. Squibb & Sons, L.L.C. | 11 | $287 |
| Alkermes, Inc. | 7 | $231 |
| Teva Pharmaceuticals USA, Inc. | 6 | $167 |
| Vanda Pharmaceuticals Inc. | 6 | $151 |
| Neurocrine BioSciences, Inc. | 12 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
Products named: VRAYLAR, CAPLYTA, COBENFY, SPRAVATO, REXULTI, ABILIFY MAINTENA, AUSTEDO XR, FANAPT.
Industry payments across VA — which companies pay providers there.
